150 related articles for article (PubMed ID: 28222611)
1. Influence of PEG coating on the oral bioavailability of gold nanoparticles in rats.
Alalaiwe A; Roberts G; Carpinone P; Munson J; Roberts S
Drug Deliv; 2017 Nov; 24(1):591-598. PubMed ID: 28222611
[TBL] [Abstract][Full Text] [Related]
2. Oral absorption of PEG-coated versus uncoated gold nanospheres: does agglomeration matter?
Hinkley GK; Carpinone P; Munson JW; Powers KW; Roberts SM
Part Fibre Toxicol; 2015 Mar; 12():9. PubMed ID: 25884802
[TBL] [Abstract][Full Text] [Related]
3. Influence of chitosan coating on the oral bioavailability of gold nanoparticles in rats.
Alalaiwe A; Carpinone P; Alshahrani S; Alsulays B; Ansari M; Anwer M; Alshehri S; Alshetaili A
Saudi Pharm J; 2019 Feb; 27(2):171-175. PubMed ID: 30766426
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Polyethylene Glycol-Coated Gold Nanoparticle Toxicity and Inflammation In Vivo Using NF-κB Reporter Mice.
Chen TY; Chen MR; Liu SW; Lin JY; Yang YT; Huang HY; Chen JK; Yang CS; Lin KM
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33142808
[TBL] [Abstract][Full Text] [Related]
5. Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice.
Zhang G; Yang Z; Lu W; Zhang R; Huang Q; Tian M; Li L; Liang D; Li C
Biomaterials; 2009 Apr; 30(10):1928-36. PubMed ID: 19131103
[TBL] [Abstract][Full Text] [Related]
6. Effect of naked and PEG-coated gold nanoparticles on histopathology and cytokines expression in rat liver and kidneys.
Al-Harbi NS; Alrashood ST; Siddiqi NJ; Arafah MM; Ekhzaimy A; Khan HA
Nanomedicine (Lond); 2020 Feb; 15(3):289-302. PubMed ID: 31774720
[No Abstract] [Full Text] [Related]
7. A higher dose of PEGylated gold nanoparticles reduces the accelerated blood clearance phenomenon effect and induces spleen B lymphocytes in albino mice.
Abu-Dief AM; Alsehli M; Awaad A
Histochem Cell Biol; 2022 Jun; 157(6):641-656. PubMed ID: 35157114
[TBL] [Abstract][Full Text] [Related]
8. Tissue distribution of gold and silver after subacute intravenous injection of co-administered gold and silver nanoparticles of similar sizes.
Lee JH; Sung JH; Ryu HR; Song KS; Song NW; Park HM; Shin BS; Ahn K; Gulumian M; Faustman EM; Yu IJ
Arch Toxicol; 2018 Apr; 92(4):1393-1405. PubMed ID: 29450565
[TBL] [Abstract][Full Text] [Related]
9. Size-dependent radiosensitization of PEG-coated gold nanoparticles for cancer radiation therapy.
Zhang XD; Wu D; Shen X; Chen J; Sun YM; Liu PX; Liang XJ
Biomaterials; 2012 Sep; 33(27):6408-19. PubMed ID: 22681980
[TBL] [Abstract][Full Text] [Related]
10. The effect of ligand composition on the in vivo fate of multidentate poly(ethylene glycol) modified gold nanoparticles.
Liu X; Huang N; Wang H; Li H; Jin Q; Ji J
Biomaterials; 2013 Nov; 34(33):8370-81. PubMed ID: 23932246
[TBL] [Abstract][Full Text] [Related]
11. Size-dependent in vivo toxicity of PEG-coated gold nanoparticles.
Zhang XD; Wu D; Shen X; Liu PX; Yang N; Zhao B; Zhang H; Sun YM; Zhang LA; Fan FY
Int J Nanomedicine; 2011; 6():2071-81. PubMed ID: 21976982
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity, intracellular localization and exocytosis of citrate capped and PEG functionalized gold nanoparticles in human hepatocyte and kidney cells.
Tlotleng N; Vetten MA; Keter FK; Skepu A; Tshikhudo R; Gulumian M
Cell Biol Toxicol; 2016 Aug; 32(4):305-21. PubMed ID: 27184667
[TBL] [Abstract][Full Text] [Related]
13. Circulation and distribution of gold nanoparticles and induced alterations of tissue morphology at intravenous particle delivery.
Terentyuk GS; Maslyakova GN; Suleymanova LV; Khlebtsov BN; Kogan BY; Akchurin GG; Shantrocha AV; Maksimova IL; Khlebtsov NG; Tuchin VV
J Biophotonics; 2009 May; 2(5):292-302. PubMed ID: 19434616
[TBL] [Abstract][Full Text] [Related]
14. The Effects of Polymer Coating of Gold Nanoparticles on Oxidative Stress and DNA Damage.
Sen GT; Ozkemahli G; Shahbazi R; Erkekoglu P; Ulubayram K; Kocer-Gumusel B
Int J Toxicol; 2020; 39(4):328-340. PubMed ID: 32483993
[TBL] [Abstract][Full Text] [Related]
15. Orthogonal analysis of functional gold nanoparticles for biomedical applications.
Tsai DH; Lu YF; DelRio FW; Cho TJ; Guha S; Zachariah MR; Zhang F; Allen A; Hackley VA
Anal Bioanal Chem; 2015 Nov; 407(28):8411-22. PubMed ID: 26362156
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal bioavailability of 2.0 nm diameter gold nanoparticles.
Smith CA; Simpson CA; Kim G; Carter CJ; Feldheim DL
ACS Nano; 2013 May; 7(5):3991-6. PubMed ID: 23600730
[TBL] [Abstract][Full Text] [Related]
17. A comparison of poly-ethylene-glycol-coated and uncoated gold nanoparticle-mediated hepatotoxicity and oxidative stress in Sprague Dawley rats.
Patlolla AK; Kumari SA; Tchounwou PB
Int J Nanomedicine; 2019; 14():639-647. PubMed ID: 30697047
[TBL] [Abstract][Full Text] [Related]
18. Effect of surface coating on the biodistribution profile of gold nanoparticles in the rat.
Morais T; Soares ME; Duarte JA; Soares L; Maia S; Gomes P; Pereira E; Fraga S; Carmo H; Bastos Mde L
Eur J Pharm Biopharm; 2012 Jan; 80(1):185-93. PubMed ID: 21946301
[TBL] [Abstract][Full Text] [Related]
19. Magnesium lithospermate B loaded PEGylated solid lipid nanoparticles for improved oral bioavailability.
Kang X; Chen H; Li S; Jie L; Hu J; Wang X; Qi J; Ying X; Du Y
Colloids Surf B Biointerfaces; 2018 Jan; 161():597-605. PubMed ID: 29156336
[TBL] [Abstract][Full Text] [Related]
20. Size- and surface chemistry-dependent pharmacokinetics and tumor accumulation of engineered gold nanoparticles after intravenous administration.
Wang J; Bai R; Yang R; Liu J; Tang J; Liu Y; Li J; Chai Z; Chen C
Metallomics; 2015 Mar; 7(3):516-24. PubMed ID: 25671498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
